Literature DB >> 8462560

Invasive infection with Mycobacterium genavense in three children with the acquired immunodeficiency syndrome.

D Nadal1, R Caduff, R Kraft, M Salfinger, T Bodmer, P Kirschner, E C Böttger, U B Schaad.   

Abstract

Three children with human immunodeficiency virus infection and invasive infection with Mycobacterium genavense are reported. Fever spikes, abdominal cramps and distension, diarrhea or ileus, and anemia were the predominant symptoms in the severely immunodeficient patients (CD4 lymphocytes < 0.04 x 10(9)/l). Numerous acid-fast bacilli were readily detectable by microscopy in stool samples and in lymph node biopsies, but cultures for mycobacteria remained negative. Mycobacterium genavense should be sought when invasive non-tuberculous mycobacteriosis is suspected and mycobacterial cultures from blood or other sites show limited growth. Multiple-drug regimens including amikacin, ethambutol, rifampin, and clarithromycin may be of benefit in controlling the infection, as observed in two patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8462560     DOI: 10.1007/bf01997055

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  13 in total

Review 1.  Mycobacterium avium complex infection in the acquired immunodeficiency syndrome.

Authors:  C R Horsburgh
Journal:  N Engl J Med       Date:  1991-05-09       Impact factor: 91.245

Review 2.  Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution.

Authors:  J J Ellner; M J Goldberger; D M Parenti
Journal:  J Infect Dis       Date:  1991-06       Impact factor: 5.226

3.  Rapid and simple method for purification of nucleic acids.

Authors:  R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

4.  Differentiation of Mycobacterium species by direct sequencing of amplified DNA.

Authors:  T Rogall; T Flohr; E C Böttger
Journal:  J Gen Microbiol       Date:  1990-09

5.  Isolation and direct complete nucleotide determination of entire genes. Characterization of a gene coding for 16S ribosomal RNA.

Authors:  U Edwards; T Rogall; H Blöcker; M Emde; E C Böttger
Journal:  Nucleic Acids Res       Date:  1989-10-11       Impact factor: 16.971

6.  The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS).

Authors:  C R Horsburgh; R M Selik
Journal:  Am Rev Respir Dis       Date:  1989-01

7.  Detection and identification of mycobacteria by amplification of rRNA.

Authors:  B Böddinghaus; T Rogall; T Flohr; H Blöcker; E C Böttger
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948

8.  Disseminated "Mycobacterium genavense" infection in patients with AIDS.

Authors:  E C Böttger; A Teske; P Kirschner; S Bost; H R Chang; V Beer; B Hirschel
Journal:  Lancet       Date:  1992-07-11       Impact factor: 79.321

9.  Mycobacterium malmoense infection in HIV positive patients.

Authors:  E J Claydon; R J Coker; J R Harris
Journal:  J Infect       Date:  1991-09       Impact factor: 6.072

10.  Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome.

Authors:  C C Hawkins; J W Gold; E Whimbey; T E Kiehn; P Brannon; R Cammarata; A E Brown; D Armstrong
Journal:  Ann Intern Med       Date:  1986-08       Impact factor: 25.391

View more
  15 in total

1.  Detection of fastidious mycobacteria in human intestines by the polymerase chain reaction.

Authors:  J M Dumonceau; A Van Gossum; M Adler; J P Van Vooren; P A Fonteyne; H De Beenhouwer; F Portaels
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-05       Impact factor: 3.267

Review 2.  Epidemiology of infection by nontuberculous mycobacteria.

Authors:  J O Falkinham
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

3.  Use of gas chromatographic fatty acid and mycolic acid cleavage product determination to differentiate among Mycobacterium genavense, Mycobacterium fortuitum, Mycobacterium simiae, and Mycobacterium tuberculosis.

Authors:  S Chou; P Chedore; S Kasatiya
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

4.  Disseminated infection with Mycobacterium genavense: a challenge to physicians and mycobacteriologists.

Authors:  V O Thomsen; U B Dragsted; J Bauer; K Fuursted; J Lundgren
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

5.  Differentiation of Mycobacterium genavense and Mycobacterium simiae by automated mycolic acid analysis with high-performance liquid chromatography.

Authors:  D Ritter; L D Carlson; B K Logan; L S Ramos; J O Kilburn; M B Coyle
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

Review 6.  Mycobacterium genavense: an emerging pathogen.

Authors:  E C Böttger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

7.  Mycobacterium genavense invasive infection in two children with AIDS: long-term followup.

Authors:  D Reymond; P Birrer; U B Schaad
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

8.  Mycobacteriosis caused by Mycobacterium genavense in birds kept in a zoo: 11-year survey.

Authors:  F Portaels; L Realini; L Bauwens; B Hirschel; W M Meyers; W de Meurichy
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

9.  Mycobacterium genavense infections in pet animals.

Authors:  T E Kiehn; H Hoefer; E C Bottger; R Ross; M Wong; F Edwards; N Antinoff; D Armstrong
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

10.  Cervical lymphadenitis caused by a fastidious mycobacterium closely related to Mycobacterium genavense in an apparently immunocompetent woman: diagnosis by culture-free microbiological methods.

Authors:  L Bosquée; E C Böttger; H De Beenhouwer; P A Fonteyne; B Hirschel; L Larsson; W M Meyers; J C Palomino; L Realini; L Rigouts
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.